Select Page
Rx.Health Platform Powers American Gastroenterological Association Unique Patient Centered National Registry with 65 sites

Rx.Health Platform Powers American Gastroenterological Association Unique Patient Centered National Registry with 65 sites

Rx.Health’s leading digital medicine platform is now enabling the Mount Sinai AppLab and the American Gastroenterology Association to collect electronic Patient Reported Outcomes (e-PROs) for an NIH-Funded Registry for Fecal Microbiota Transplantation (FMT). The FMT registry is expected to enroll and engage with 4000 patients from 65 sites in leading healthcare systems throughout North America over the next 10 years.

This collaboration is a great model of how Rx.Health can partner with medical societies and industry to create customized digital care and research plans. By using its proprietary AI and Clinical Rules Engine Rx.Health creates a continuous engagement model, reduces drop-outs, and enables the collection of real world evidence from patient and device generated data for novel devices, drugs, and digital therapeutics.To Learn more, contact engage@Rx.Health

 

Rx.Health Unveils GI Digital Medicine Toolkit, Presents Results of Two-Year HealthPROMISE Clinical Trial at Digestive Disease Week 2018

Rx.Health Unveils GI Digital Medicine Toolkit, Presents Results of Two-Year HealthPROMISE Clinical Trial at Digestive Disease Week 2018

As digital medicine continues to serve as a driving force in the evolution of patient care, Rx.Health is announcing, in partnership with the AppLab at Mount Sinai, the release of a transformative Gastrointestinal Digital Medicine Toolkit at Digestive Disease Week 2018 in Washington, DC.  This end-to-end solution is the first of its kind in the field of gastroenterology, and allows both patients and providers to realize the myriad of benefits from combining multiple proven and complimentary digital solutions in a single toolkit for GI diseases and endoscopy procedures.

The Toolkit allows providers to prescribe patients a care plan that evolves with the patient’s condition.  Included in the offering are clinically-proven tracking apps, telemedicine support services, scheduling and feedback reminders, as well as solutions that provide a holistic approach to patient care, such as patient social outreach engagement and ongoing health education materials.  An additional core component of the Toolkit is HealthPROMISE, an app-based platform developed at Mount Sinai that is designed to improve the quality of care for those patients struggling with inflammatory bowel disease.

When asked about the significance of the GI Digital Medicine Toolkit, Pavan Choksi, who serves as Rx.Health’s Vice President of Corporate Development and Transformation Lead, noted that “Digital Medicine presents a unique opportunity for providers to treat patients on a continual basis, and not just during office hours.  But like anything, you need the right mechanism in place to do this effectively.  The Toolkit combines the strongest offerings that are complimentary with one another to optimize not just procedural outcomes, but also the general patient experience.”

In conjunction with the release of the GI Digital Medicine Toolkit, Mount Sinai’s AppLab will be presenting the results of a two-year clinical trial of HealthPROMISE on Saturday, June 2nd, at the Mount Sinai Booth at DDW.  In addition to the presentation, representatives from AppLab will also be demonstration of the unique GI BOT.  Please stop by booth #1407 to discuss how digital medicine could transform your practice or care.

Dr. Atreja to Speak on the Clinical Research behind Digital Medicine at Annual APCR Meeting

Dr. Atreja to Speak on the Clinical Research behind Digital Medicine at Annual APCR Meeting

On Oct. 21, Rx.Health Cofounder Dr. Ashish Atreja will address the Academy of Physicians in Clinical Research at the second annual meeting in Orlando, Florida. A noted authority on the subject, Dr. Atreja will engage the APCR in a discussion centered on harnessing the dual power of Digital Medicine and an empowered patient population in order to change the future of clinical research.

Dr. Atreja will be joined by Dr. Michael Koren, who serves as the Vice President of the APCR and chair of the annual meeting, and is also the CEO and Director of the Jacksonville Center for Clinical Research.

The APCR presents the perfect forum to host a dialogue on the implications of Digital Medicine on clinical research. As an independent, nonprofit membership organization, the APCR is comprised of clinicians and researchers dedicated to promoting the welfare of patients through the acquisition, dissemination, and evaluation of knowledge focused on medicine and device development.

This year’s conference will cover a diverse range of topics ranging from the rising costs of prescription medication to patient access to new medicines. Discussions will focus on innovation in clinical trials and the ability of such innovation to impact and/or benefit from patient involvement in research. Dr. Atreja’s discussion on Digital Medicine will occur on the second day of the event, which is the same day as the conference’s unique interactive session on conducting clinical studies.

The event will be hosted at the Wyndham Grand Resort Bonnet Creek from October 20 through 22. Please contact Dr. Atreja if you plan on being in attendance and would like to discuss the potential benefits of Digital Medicine to your practice or health system.

Responsive Health Joins with Medical Technology Innovators at Health IMPACT East

Responsive Health co-founders Dr. Ashish Atreja and Ed Berde, along with VP of Corporate Development, Pavan Choksi, met with
numerous C-Level Healthcare executives and providers at the HealthIMPACT East Conference on Monday, June 5.

As one of the conference’s innovation partners, Responsive Health led discussions with NODE Health during a comprehensive, rapid fire-round table discussion focused on defining Digital Medicine and its pivotal role in the future of healthcare.

“I’m passionate about Digital Medicine and changing the way that people view digital health,” Mr. Berde said during the discussion. “With Responsive Health, we have three goals: first, define Digital Medicine and educate providers; second, validate Digital Medicine solutions; and third, provide a back bone for innovation across health systems.”

Dr. Atreja, also led several engaging conversations throughout the day. Topics included how digital innovation is suffering from a lack of shared evidence, examples of successful implementation and how organizations are collaborating to utilize innovation in order to realize transformation.

“Digital Medicine needs to be reproducible,” Dr. Atreja said. “The focus needs to be on technology that produces uniform results for clinicians, which then promotes integration into health systems and adoption by practitioner and patient alike.”

Other featured speakers and panelists included Bruce Darrow, the Chief Medical Information Officer at Mount Sinai; Ram Raju, the Senior Vice President of Northwell Health; Mandi Bishop, Founder and CEO of Lifely Insigts; Victoria Tiase, the Director of Informatics Strategy at New York Presbyterian Hospital and Gregory Downing, Founder of Innovation Horizons.